Select Publications

Eremina V et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008;358(11):1129-36. Abstract

Feldman DR et al. Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC). Proc ASCO 2007;Abstract 5099.

Hudes G et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007;356(22):2271-81. Abstract

Motzer RJ et al. RAD001 vs placebo in patients with metastatic renal cell carcinoma (RCC) after progression on VEGFr-TKI therapy: Results from a randomized, double-blind, multicenter phase-III study. Proc ASCO 2008;Abstract LBA5026.

Ratain MJ et al. Preliminary antitumor activity of BAY 43-9006 in metastatic renal cell carcinoma and other advanced refractory solid tumors in a phase II randomized discontinuation trial (RDT). Proc ASCO 2004;Abstract 4501.

 

 

 

 

 

 

 

 

 

 

 

 

 

Home

Editor
Neil Love, MD

Interviews

Robert A Figlin, MD
- Select publications

Gary R Hudes, MD
- Select publications

Ronald M Bukowski, MD
- Select publications

CME Information

Faculty Disclosures

Editor's Office